Programmaleider Zorg en Participatie bij Chronische aandoeningen; bijzonder hoogleraar 'Farmaceutisch zorgonderzoek', Rijksuniversiteit Groningen
Publicatie
Publicatie datum
Do the benefits of statins outweigh their drawbacks? Assessing patients' trade-off preferences with conjoint analysis.
Wouters, H., Dijk, L. van, Geffen, E.C.G. van, Geers, H.C.J., Souverein, P.C., Bouvy, M.L., Stiggelbout, A.M. Do the benefits of statins outweigh their drawbacks? Assessing patients' trade-off preferences with conjoint analysis. International Journal of Cardiology: 2014, 176(3), p. 1220-1222.
Download de PDF
Efficacious lowering of low-density lipoprotein cholesterol through prolonged statin therapy has become a major strategy for primary and secondary prevention of cardiovascular disease. From the perspective of patients, however, the prophylactic efficacy may be difficult to comprehend. It refers to prospective disease prevention at the population level and an uncertain risk reduction for individual patients. At the same time, actual side effects may occur and treatment entails a lifelong regimen. (aut. ref.)
Efficacious lowering of low-density lipoprotein cholesterol through prolonged statin therapy has become a major strategy for primary and secondary prevention of cardiovascular disease. From the perspective of patients, however, the prophylactic efficacy may be difficult to comprehend. It refers to prospective disease prevention at the population level and an uncertain risk reduction for individual patients. At the same time, actual side effects may occur and treatment entails a lifelong regimen. (aut. ref.)